192379-41-2

Upstream product

• 168412-05-3 4-amino-1-benzylimidazole-5-glyoxal (N²-benzyl-N²-methoxycarbonyl)hydrazone 
• 99686-99-4 1-benzyl-5-methyl-4-nitro-1H-imidazole 
• 168412-06-4 trans-1-benzyl-5-<β-(N,N-dimethylamino)ethylene>-4-nitroimidazole 
• 168412-09-7 1-benzyl-4-nitroimidazole-5-glyoxal (N²-methoxycarbonyl)hydrazone 
• 168412-08-6 1-benzyl-4-nitroimidazole-5-acetaldehyde (N²-carbomethoxy)hydrazone 
• 192379-39-8 1-benzyl-4-nitroimidazole-5-glyoxal (N²-benzyl-N²-methoxycarbonyl)hydrazone 

Downstream Products

• 505073-75-6 4-amino-1-benzylimidazole-5-glyoxal (N²-benzyl-N²-p-nitrophenoxycarbonyl)hydrazone 

Relevant academic research and scientific papers

Synthesis of a novel ring-expanded purine analogue containing a 5:8-fused imidazo[4,5-e][1,2,4]triazocine ring system amidst opportunistic rearrangements and ring transformations

A novel 5:8-fused heterocycle containing the imidazo[4,5-e][1,2,4]triazocine ring system has been synthesized in ten steps commencing from 1-benzyl-5-methyl-4-nitroimidazole. The compound is a new member of the family of ring-expanded xanthine-xanthosine analogues reported from this laboratory. The synthesis led to the unraveling of a number of novel rearrangements and ring-transformations.